Menopause & midlife

SSRIs for Hot Flashes: How Well They Work

Save

Certain antidepressants ease menopausal hot flashes; low-dose paroxetine is FDA-approved for this use, and SSRIs and SNRIs like venlafaxine are used off-label. They cut hot-flash frequency and severity more than placebo but usually less than hormone therapy, often within 1 to 2 weeks. A clinician matches it to your history.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Can antidepressants really help hot flashes?

Antidepressants can reduce hot flashes independently of any effect on mood. Serotonin and norepinephrine, the brain chemicals these medicines act on, also influence the body's temperature-regulation circuits, which is why low doses can ease vasomotor symptoms. The North American Menopause Society lists certain SSRIs and SNRIs among its recommended non-hormonal treatments for hot flashes 1. An earlier position statement reached the same conclusion, giving this approach more than a decade of supporting evidence 2. Relief often appears faster than the antidepressant effect on depression — frequently within 1 to 2 weeks — and at lower doses than are typically used for mood 1. That makes them a practical option when hormones are off the table, whether by choice or medical need 5.

Which antidepressants work best for hot flashes?

A handful of specific SSRIs and SNRIs have the strongest evidence for vasomotor symptoms. Low-dose paroxetine is the only one the FDA has approved specifically for hot flashes, marketed for this use as a dedicated low-dose product 1. Venlafaxine, desvenlafaxine, escitalopram, and citalopram are commonly used off-label with trial support, while some other antidepressants show little benefit 12. Choice often turns on other factors: a woman with coexisting low mood or anxiety, such as perimenopause mood changes, may value a medicine that addresses both. Because responses differ, a clinician may adjust the specific agent, and knowing how long antidepressants take to work sets realistic expectations for the trial period.

How well do they work compared with hormones?

Antidepressants offer meaningful but moderate relief, less than hormone therapy but clearly better than placebo. Trials show these medicines reduce hot-flash frequency and severity to a moderate degree, whereas hormone therapy remains the most effective single option, cutting frequency by roughly 75% for many women 3. For someone who cannot take estrogen — for example, after some hormone-sensitive breast cancers — a moderate non-hormonal benefit can still be valuable 1. Hot flashes can persist a long time, with a median of about 7.4 years in the SWAN cohort, so the durability of treatment matters when comparing options 4. Weighing these medicines against other ways to stop hot flashes helps set expectations rather than hoping for complete elimination.

What should I know about side effects and stopping?

These medicines have real considerations, even at the low doses used for hot flashes. Possible effects include nausea, dry mouth, sleep changes, and sexual side effects, and they can vary by drug. One important interaction stands out: paroxetine can interfere with tamoxifen, so for breast cancer survivors on that medicine, clinicians often choose a different agent such as venlafaxine 1. Stopping suddenly can cause discontinuation symptoms, so changes are tapered with guidance rather than abrupt. A newer non-hormonal pill, fezolinetant, is another option to weigh. Because these are prescription decisions, a clinician — and often a primary care clinician can prescribe them — reviews benefits, interactions, and your history.

When antidepressants for hot flashes need a clinician

A gynecologist, menopause clinician, or primary care clinician can decide whether an antidepressant is a good match for your hot flashes. That conversation is especially useful when hormones are unsuitable, when you also have low mood or anxiety, or when you take medicines such as tamoxifen that affect the choice. Bring your full medication list, your history, and a sense of how often flashes occur and how much they bother you. Because relief and side effects both take a few weeks to judge, plan on a follow-up to reassess. Gale can help you prepare for that conversation.

Common questions

No. These medicines reduce hot flashes through their effect on temperature-regulation circuits, separate from their effect on mood, and are used at low doses for this purpose. That said, if you also have low mood or anxiety, one medicine may help both.

Low-dose paroxetine is the only antidepressant the FDA has approved specifically for menopausal hot flashes. Others, such as venlafaxine, desvenlafaxine, and escitalopram, are used off-label with trial evidence supporting them. A clinician chooses based on your history and other symptoms.

Most people see moderate relief — a meaningful drop in how often and how severe flashes are, though usually less than hormone therapy provides. Benefit often appears within one to two weeks. If relief is inadequate after a fair trial, a clinician can adjust the plan.

It is best not to stop abruptly. Stopping suddenly can cause discontinuation symptoms, so changes are usually made gradually with a clinician's guidance. This is a routine part of treatment planning and not a reason to avoid trying the medicine.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Using antidepressants for hot flashes safely

  • —New or worsening thoughts of self-harm after starting a medicine are a reason to seek urgent support — in the U.S. you can call or text 988
  • —Taking tamoxifen for breast cancer is a reason to seek clinician review before using paroxetine, which can interfere with it
  • —Agitation, confusion, fever, or muscle twitching after a dose change is a reason to seek prompt clinician review
  • —Stopping the medicine abruptly is a reason to seek clinician guidance to avoid discontinuation symptoms

If you have thoughts of harming yourself, call or text 988 (the Suicide and Crisis Lifeline) right away, or call 911 or go to the nearest emergency room.

This article is general health education, not medical advice. Whether an antidepressant is appropriate for your hot flashes is a decision for a prescribing clinician such as a gynecologist, menopause clinician, or primary care clinician.

References

  1. 1.The North American Menopause Society (Menopause Society) (2023). The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause. doi:10.1097/GME.0000000000002200 ✓Certain SSRIs and SNRIs are recommended non-hormonal treatments for vasomotor symptoms; low-dose paroxetine is FDA-approved for hot flashes, relief often appears within weeks, and paroxetine can interfere with tamoxifen.
  2. 2.The North American Menopause Society (Menopause Society) (2015). Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause. doi:10.1097/GME.0000000000000546 ✓An earlier position statement similarly identified specific SSRIs and SNRIs as effective non-hormonal options for vasomotor symptoms, giving the approach longstanding evidentiary support.
  3. 3.The North American Menopause Society (Menopause Society) (2022). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. doi:10.1097/GME.0000000000002028 ✓Hormone therapy is the most effective treatment for vasomotor symptoms, reducing frequency by roughly 75% for many women, providing the comparison for antidepressant efficacy.
  4. 4.Avis NE, Crawford SL, Greendale G, et al. / Study of Women's Health Across the Nation (SWAN) (2015). Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Internal Medicine. doi:10.1001/jamainternmed.2014.8063 ✓Frequent vasomotor symptoms lasted a median of about 7.4 years in the SWAN cohort, underscoring why durable treatment options matter.
  5. 5.Office on Women's Health (U.S. HHS) (2026). Menopause basics. Office on Women's Health (womenshealth.gov), U.S. HHS. link ✓Hot flashes are a common menopausal symptom, and both hormonal and non-hormonal prescription options are available to manage them.

5 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library